Mostrar el registro sencillo del ítem
GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis
dc.contributor.author | Estrada Capetillo, Lizbeth | |
dc.date.accessioned | 2021-05-04T17:28:29Z | |
dc.date.available | 2021-05-04T17:28:29Z | |
dc.date.issued | 2021-02-17 | es_MX |
dc.identifier.uri | http://cathi.uacj.mx/20.500.11961/18356 | |
dc.description.abstract | Background and Aims: GM-CSF-dependent macrophage polarization has been demonstrated in rheumatoid arthritis (RA). Our aim was to seek diagnostic/prognostic biomarkers for undifferentiated arthritis (UA) by analyzing GM-CSF expression and source, macrophage polarization and density in joints of patients with UA evolving to RA or PsA compared with established RA or PsA, respectively. Methods: Synovial tissue (ST) from patients with UA evolving to RA (UA>RA, n=8), PsA (UA>PsA, n=9), persistent UA (UA, n=16), established RA (n=12) and PsA (n=10), and healthy controls (n=6), were analyzed. Cell source and quantitative expression of GM-CSF and proteins associated with pro-inflammatory (GM-CSF-driven) and anti-inflammatory (M- CSF-driven) macrophage polarization (activin A, TNFa, MMP12, and CD209, respectively) were assessed in ST CD163+ macrophages by multicolor immunofluorescence. GM-CSF and activin A levels were also quantified in paired synovial fluid samples. CD163+ macrophage density was determined in all groups by immunofluorescence. Results: Synovial stromal cells (FAP+ CD90+ fibroblast, CD90+ endothelial cells) and CD163+ sublining macrophages were the sources of GM-CSF. ST CD163+ macrophages from all groups expressed pro-inflammatory polarization markers (activin A, TNFa, and MMP12). Expression of the M-CSF-dependent anti-inflammatory marker CD209 identified two macrophage subsets (CD163+ CD209high and CD163+ CD209low/-). CD209+ macrophages were more abundant in ST from healthy controls and PsA patients, although both macrophage subtypes showed similar levels of pro-inflammatory markers in all groups. In paired synovial fluid samples, activin A was detected in all patients, with higher levels in UA>RA and RA, while GM-CSF was infrequently detected. ST CD163+ macrophage density was comparable between UA>RA and UA>PsA patients, but significantly higher than in persistent UA. Conclusions: GM-CSF is highly expressed by sublining CD90+ FAP+ synovial fibroblasts, CD90+ activated endothelium and CD163+ macrophages in different types of arthritis. The polarization state of ST macrophages was similar in all UA and established arthritis groups, with a predominance of pro-inflammatory GM-CSF-associated markers. CD163+ macrophage density was significantly higher in the UA phases of RA and PsA compared with persistent UA. Taken together, our findings support the idea that GM- CSF is a strong driver of macrophage polarization and a potential therapeutic target not only in RA but also in PsA and all types of UA | es_MX |
dc.description.uri | https://www.frontiersin.org/articles/10.3389/fimmu.2020.613975/full | es_MX |
dc.language.iso | en | es_MX |
dc.relation.ispartof | Producto de investigación ICB | es_MX |
dc.relation.ispartof | Instituto de Ciencias Biomédicas | es_MX |
dc.rights | Atribución-NoComercial-SinDerivadas 2.5 México | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/mx/ | * |
dc.subject | Autoinmunidad | es_MX |
dc.subject | Macrófagos | es_MX |
dc.subject | gm-csf | es_MX |
dc.subject | artritis | es_MX |
dc.subject.other | info:eu-repo/classification/cti/2 | es_MX |
dc.title | GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis | es_MX |
dc.type | Artículo | es_MX |
dcterms.thumbnail | http://ri.uacj.mx/vufind/thumbnails/rupiicb.png | es_MX |
dcrupi.instituto | Instituto de Ciencias Biomédicas | es_MX |
dcrupi.cosechable | Si | es_MX |
dcrupi.volumen | 11 | es_MX |
dcrupi.nopagina | 1-13 | es_MX |
dc.identifier.doi | https://doi.org/10.3389/fimmu.2020.613975 | es_MX |
dc.contributor.coauthor | Estrada Capetillo, Lizbeth | |
dc.journal.title | Frontiers in Immunology | es_MX |
dc.lgac | Ciencias de la Salud | es_MX |
dc.cuerpoacademico | Sin cuerpo académico | es_MX |
dc.contributor.authorexterno | Fuentelsaz Romero, Sara | |
dc.contributor.coauthorexterno | Cuervo, Andrea | |
dc.contributor.coauthorexterno | Celis, Raquel | |
dc.contributor.coauthorexterno | García Campos, Raquel | |
dc.contributor.coauthorexterno | Ramírez, Julio | |
dc.contributor.coauthorexterno | Sergi, Sastre | |
dc.contributor.coauthorexterno | Samaniego, Rafael | |
dc.contributor.coauthorexterno | Puig-Kröger, Amaya | |
dc.contributor.coauthorexterno | Cañete, Juan D. | |
dcrupi.colaboracionext | España | es_MX |